Home › Cancro del polmone non a piccole cellule › Maryland › Germantown
Studi clinici su Cancro del polmone non a piccole cellule a Germantown, MD
17 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Germantown e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
In reclutamentoFase 1/2
- Virgnia Cancer Specialists /ID# 269633, Leesburg · a 16 mi di distanza
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · a 4 mi di distanza
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
In reclutamentoFase 3
- Maryland Oncology Hematology (MOH) ( Site 8102), Rockville · a 9 mi di distanza
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
In reclutamentoFase 3
- Maryland Oncology Hematology P.A., Germantown
- Maryland Oncology Hematology PA, Rockville · a 9 mi di distanza
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
In reclutamentoFase 3
- Research Site, Frederick · a 18 mi di distanza
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Maryland Oncology Hematology, P.A., Germantown
- Maryland Oncology Hematology, P.A., Rockville · a 9 mi di distanza
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
In reclutamentoFase 3
- James M Stockman Cancer Institute, Frederick · a 18 mi di distanza
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
In reclutamentoFase 3
- Research Site, Leesburg · a 16 mi di distanza
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
In reclutamentoFase 2/3
- Frederick Health Hospital- James M Stockman Cancer Institute, Frederick · a 18 mi di distanza
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
In reclutamentoFase 2/3
- Local Institution - 007-814-C, Leesburg · a 16 mi di distanza
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
In reclutamentoFase 3
- Inova Loudoun Hospital, Leesburg · a 16 mi di distanza
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
In reclutamentoFase 1/2
- USOR Maryland Oncology Hematology, Rockville · a 9 mi di distanza
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
In reclutamentoStudio osservazionale
- Frederick Health Hospital, Frederick · a 18 mi di distanza
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · a 4 mi di distanza
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · a 4 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · a 4 mi di distanza
GEMINI-NSCLC: NSCLC Biomarker Study
In reclutamentoStudio osservazionale
- Frederick Health Regional System, Frederick · a 18 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Germantown
- Schizofrenia11 studi
- Cancro al seno10 studi
- Cancro ai polmoni9 studi
- Cancro (tutti i tipi)7 studi
- Depressione7 studi
- Obesità7 studi
- Diabete di tipo 27 studi
- Malattie cardiovascolari6 studi
- Cancro della vescica6 studi
- Sovrappeso5 studi
- Disturbo depressivo maggiore5 studi
- Pressione alta4 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.